L19TNF + Doxorubicin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for L19TNF + Doxorubicin, covering 2024-04-08 to 2024-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 3]